175 related articles for article (PubMed ID: 36138703)
1. Time of Onset and Risk Factors of Renal Involvement in Children with Henoch-Schönlein Purpura: Retrospective Study.
Carucci NS; La Barbera G; Peruzzi L; La Mazza A; Silipigni L; Alibrandi A; Santoro D; Chimenz R; Conti G
Children (Basel); 2022 Sep; 9(9):. PubMed ID: 36138703
[TBL] [Abstract][Full Text] [Related]
2. Do practical laboratory indices predict the outcomes of children with Henoch-Schönlein purpura?
Ekinci RMK; Balci S; Sari Gokay S; Yilmaz HL; Dogruel D; Altintas DU; Yilmaz M
Postgrad Med; 2019 May; 131(4):295-298. PubMed ID: 31021301
[No Abstract] [Full Text] [Related]
3. Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center.
Buscatti IM; Casella BB; Aikawa NE; Watanabe A; Farhat SCL; Campos LMA; Silva CA
Clin Rheumatol; 2018 May; 37(5):1319-1324. PubMed ID: 29330742
[TBL] [Abstract][Full Text] [Related]
4. Proteome analysis reveals novel serum biomarkers for Henoch-Schönlein purpura in Chinese children.
Liu L; Liu H; Zhu K; Zhang L; Yin X; Han L; Wang M; Gao S; Xiao X; Yang J; Huang C; Huang Y
J Proteomics; 2023 Mar; 276():104841. PubMed ID: 36796721
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study.
Song YR; Guo WL; Sheng M; Lin Q; Zhu XM; Li XZ
BMC Pediatr; 2020 Nov; 20(1):501. PubMed ID: 33131493
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis].
Ru L; Abudouhaer A; Guo YF
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):1009-13. PubMed ID: 24229600
[TBL] [Abstract][Full Text] [Related]
7. Exploring potential predictors of Henoch-Schönlein purpura nephritis: a pilot investigation on urinary metabolites.
Yu M; Song X; Guo J; Feng Q; Tian J
Eur J Pediatr; 2024 Apr; ():. PubMed ID: 38668796
[TBL] [Abstract][Full Text] [Related]
8. A retrospective analysis of children with Henoch-Schonlein purpura and re-evaluation of renal pathologies using Oxford classification.
Çakıcı EK; Gür G; Yazılıtaş F; Eroğlu FK; Güngör T; Arda N; Orhan D; Özalp Ateş FS; Bülbül M
Clin Exp Nephrol; 2019 Jul; 23(7):939-947. PubMed ID: 30895528
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.
Torun Bayram M; Heybeli C; Yıldız G; Soylu A; Celik A; Sarioglu S; Kavukçu S
Int Urol Nephrol; 2022 Aug; 54(8):1925-1932. PubMed ID: 34846620
[TBL] [Abstract][Full Text] [Related]
10. Increased CD8+ T cells in patients with Henoch-Schonlein purpura nephritis exhibit suppressive immune activity.
Fengyong Z; Zhixiang F; Jiajia P; Qin L; Min Q; Guoliang W; Ziyan Z
Immunol Lett; 2022 Oct; 250():23-28. PubMed ID: 36174770
[TBL] [Abstract][Full Text] [Related]
11. [Clinical Significance of Serum Midkine in Children with Henoch-Schonlein Purpura].
Li MM; Liu N; Zhagn M; Xue HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):181-185. PubMed ID: 28245398
[TBL] [Abstract][Full Text] [Related]
12. The relevance of practical laboratory markers in predicting gastrointestinal and renal involvement in children with Henoch-Schönlein Purpura.
Karadağ ŞG; Çakmak F; Çil B; Tanatar A; Sönmez HE; Kıyak A; Yavuz S; Çakan M; Aktay Ayaz N
Postgrad Med; 2021 Apr; 133(3):272-277. PubMed ID: 32772751
[TBL] [Abstract][Full Text] [Related]
13. Henoch-Schönlein Purpura in Children: An Updated Review.
Leung AKC; Barankin B; Leong KF
Curr Pediatr Rev; 2020; 16(4):265-276. PubMed ID: 32384035
[TBL] [Abstract][Full Text] [Related]
14. Predictive role of neutrophil to lymphocyte ratio and mean platelet volume in Henoch-Schönlein purpura related gastrointestinal and renal involvement.
Yakut HI; Kurt T; Uncu N; Semsa Cayci F; Celikel Acar B
Arch Argent Pediatr; 2020 Apr; 118(2):139-142. PubMed ID: 32199052
[TBL] [Abstract][Full Text] [Related]
15. Analysis of children with Henoch-Schonlein purpura secondary to infection.
Liu C; Luo L; Fu M; Li Z; Liu J
Clin Rheumatol; 2022 Mar; 41(3):803-810. PubMed ID: 34993728
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of creatine phosphate sodium for the treatment of Henoch-Schönlein purpura in patients with early renal damage detected using urinary kidney injury molecule-1 levels.
Zhang J; Zeng H; Wang N; Tian X; Dou W; Shi P
Eur J Pediatr; 2016 Jan; 175(1):49-55. PubMed ID: 26220440
[TBL] [Abstract][Full Text] [Related]
17. Age Related Characteristics Of Children And Adolescent With Henoch Schönlein Purpura And Systems Involvement: An Experience From Tertiary Care Center.
Aziz DA; Siddiqui F; Siddiqui MT
J Ayub Med Coll Abbottabad; 2022; 34(2):336-340. PubMed ID: 35576298
[TBL] [Abstract][Full Text] [Related]
18. Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management.
Chen JY; Mao JH
World J Pediatr; 2015 Feb; 11(1):29-34. PubMed ID: 25557596
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for renal involvement in Henoch-Schönlein purpura.
Kim WK; Kim CJ; Yang EM
J Pediatr (Rio J); 2021; 97(6):646-650. PubMed ID: 33722533
[TBL] [Abstract][Full Text] [Related]
20. Obesity is associated with Henoch-Schönlein Purpura Nephritis and development of end-stage renal disease in children.
Zheng X; Chen Q; Chen L
Ren Fail; 2019 Nov; 41(1):1016-1020. PubMed ID: 31735105
[No Abstract] [Full Text] [Related]
[Next] [New Search]
